Skip to main content
. Author manuscript; available in PMC: 2016 Feb 17.
Published in final edited form as: Acad Pediatr. 2013 Sep 8;13(6):508–516. doi: 10.1016/j.acap.2013.07.003

Table 1.

Sample characteristics and ETS exposure status, children 6-19 years of agea with asthmab, United States, 2003-2010

Unweighted
number
Weighted
%
ETS
exposedc
% (SE)
p-valued
Total n 925 100 53.3 (3.2)
Age group
 6-11 years 364 40.5 58.6 (4.2) 0.05
 12-19 years 561 59.5 49.7 (3.7)
Sex
 Male 506 53.4 51.6 (3.8) 0.45
 Female 419 46.6 55.2 (4.2)
Race/ethnicity
 Non-Hispanic
white
235 55.9 52.2 (5.2) <0.001
 Non-Hispanic black 354 20.6 67.9 (3.3)
 Mexican American 202 10.2 37.5 (3.3)
 Other 134 13.3 41.1 (6.4)
Poverty status
 <1.85 PIR 508 42.3 72.0 (2.6) <0.001
 ≥1.85 PIR 417 57.7 39.5 (4.0)
Home ownership
 Owns home 529 68.4 43.6 (4.3) <0.001
 Rents/other 396 31.6 74.2 (3.2)
Household size
 4 or fewer 490 58.3 53.8 (3.6) 0.77
 5 or more 435 41.7 52.6 (4.1)
Preventive asthma medication
 Yes, in past month 248 31.0 48.5 (5.8) 0.18
 No 677 69.0 55.4 (2.9)

PIR: poverty income ratio

a

Excludes smokers (children with serum cotinine level >10ng/mL or 12-19 year olds who reported use of tobacco products in the previous 5 days)

b

Current asthma is defined as reporting ever receiving a diagnosis of asthma from a health professional and having asthma at the time of the health survey.

c

Defined as serum cotinine level 0.5-10.0 ng/mL

d

p-value for family-wide chi square test